Evidence map›Paper›PMID 39737984›Full record

ArticleNature communications2024

Structural insights into how Cas9 targets nucleosomes.

Reina Nagamura, Tomoya Kujirai, Junko Kato, Yutaro Shuto, Tsukasa Kusakizako, Hisato Hirano, Masaki Endo, Seiichi Toki, Hiroaki Saika, Hitoshi Kurumizaka and 1 more

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Targeted mutagenesis and base editing using engineeredPlant biotechnology (Tokyo, Japan) · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. CRISPR-epigenetic crosstalk: From bidirectional regulation to therapeutic potential.Computational and structural biotechnology journal · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Reina NagamuraDepartment of Biological Sciences, Graduate School of Science, The University of Tokyo, Tokyo, Japan.
Tomoya KujiraiInstitute for Quantitative Biosciences, Department of Biological Sciences, Graduate School of Science, The University of Tokyo, Tokyo, Japan.
Junko KatoInstitute for Quantitative Biosciences, Department of Biological Sciences, Graduate School of Science, The University of Tokyo, Tokyo, Japan.
Yutaro ShutoDepartment of Biological Sciences, Graduate School of Science, The University of Tokyo, Tokyo, Japan.ORCID 0009-0007-8710-4134
Tsukasa KusakizakoDepartment of Biological Sciences, Graduate School of Science, The University of Tokyo, Tokyo, Japan.ORCID 0000-0002-6186-6647
Hisato HiranoDepartment of Biological Sciences, Graduate School of Science, The University of Tokyo, Tokyo, Japan.
Masaki EndoDivision of Crop Genome Editing Research, Institute of Agrobiological Sciences, National Agriculture and Food Research Organization, Tsukuba, Japan.
Seiichi TokiDivision of Crop Genome Editing Research, Institute of Agrobiological Sciences, National Agriculture and Food Research Organization, Tsukuba, Japan.
Hiroaki SaikaDivision of Crop Genome Editing Research, Institute of Agrobiological Sciences, National Agriculture and Food Research Organization, Tsukuba, Japan.
Hitoshi KurumizakaInstitute for Quantitative Biosciences, Department of Biological Sciences, Graduate School of Science, The University of Tokyo, Tokyo, Japan. kurumizaka@iqb.u-tokyo.ac.jp.ORCID 0000-0001-7412-3722
Osamu NurekiDepartment of Biological Sciences, Graduate School of Science, The University of Tokyo, Tokyo, Japan. nureki@bs.s.u-tokyo.ac.jp.ORCID 0000-0003-1813-7008

Funding

Japan Agency for Medical Research and Development (AMED) JP19am0401005Japan Agency for Medical Research and Development (AMED) JP23ama121002Japan Agency for Medical Research and Development (AMED) JP23ama121009Japan Agency for Medical Research and Development (AMED) JP23ama121012Japan Agency for Medical Research and Development (AMED) JP23fa627001MEXT | Japan Society for the Promotion of Science (JSPS) JP23H05475MEXT | JST | Exploratory Research for Advanced Technology (ERATO) JPMJER1901
6 · The paper itself

Abstract

The CRISPR-associated endonuclease Cas9 derived from prokaryotes is used as a genome editing, which targets specific genomic loci by single guide RNAs (sgRNAs). The eukaryotes, the target of genome editing, store their genome DNA in chromatin, in which the nucleosome is a basic unit. Despite previous structural analyses focusing on Cas9 cleaving free DNA, structural insights into Cas9 targeting of DNA within nucleosomes are limited, leading to uncertainties in understanding how Cas9 operates in the eukaryotic genome. In the present study, we perform native-polyacrylamide gel electrophoresis (PAGE)  analyses and find that Cas9 targets the linker DNA and the entry-exit DNA region of the nucleosome but not the DNA tightly wrapped around the histone octamer. We further determine cryo-electron microscopy (cryo-EM) structure of the Cas9-sgRNA-nucleosome ternary complex that targets linker DNA in nucleosomes. The structure suggests interactions between Cas9 and nucleosomes at multiple sites. Mutants that reduce the interaction between nucleosomal DNA and Cas9 improve nucleosomal DNA cleavage activity in vitro, although inhibition by the interaction between Cas9 and nucleosomes is limited in vivo. These findings will contribute to the development of novel genome editing tools in chromatin.

Indexed as

CRISPR-Associated Protein 9Cryoelectron MicroscopyDNAGene EditingNucleosomesRNA, Guide, CRISPR-Cas SystemsChromatinCRISPR-Cas SystemsDNA CleavageHistonesModels, MolecularChromatinCRISPR-Associated Protein 9DNAHistonesNucleosomesRNA, Guide, CRISPR-Cas Systems

Identifiers

PMID39737984
PMCPMC11685650

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.